GH Guardant Health, Inc.

NASDAQ
$174.75

Guardant Health, Inc. (GH) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Subdued Selling ran below GH's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 10 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
8 transactions
Purchases
$0
0 shares
Sales
$3.3M
19,354 shares
Net activity
-$3.3M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $3.3M 8 transactions · 19,354 shares

Largest single sale: $1.4M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: June 15, 2026 , by Kalia Kumud .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Krognes Steve E. 4 fills Director Sell 6,674 $175.74 $1.2M 13,477 −33.1% of holding
Azar Alex M II Director Sell 826 $175.00 $144.6K 825 −50% of holding
Tariq Musa Director Sell 116 $175.00 $20.3K 11,449 −1% of holding
Chudova Darya Chief Technology Officer Sell 7,738 $178.00 $1.4M 70,635 −9.9% of holding
Kalia Kumud Chief Information Officer Sell 4,000 $158.05 $632.2K 39,794 −9.1% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.